286 related articles for article (PubMed ID: 1880254)
41. Methotrexate use in psoriasis and psoriatic arthritis.
Cuellar ML; Espinoza LR
Rheum Dis Clin North Am; 1997 Nov; 23(4):797-809. PubMed ID: 9361156
[TBL] [Abstract][Full Text] [Related]
42. Elevated serum aminoterminal procollagen type-III-peptide parallels collagen accumulation in rats with secondary biliary fibrosis.
Gerling B; Becker M; Waldschmidt J; Rehmann M; Schuppan D
J Hepatol; 1996 Jul; 25(1):79-84. PubMed ID: 8836905
[TBL] [Abstract][Full Text] [Related]
43. Serum laminin and type III procollagen in chronic hepatitis C. Diagnostic value in the assessment of disease activity and fibrosis.
Gabrielli GB; Capra F; Casaril M; Squarzoni S; Tognella P; Dagradi R; De Maria E; Colombari R; Corrocher R; De Sandre G
Clin Chim Acta; 1997 Sep; 265(1):21-31. PubMed ID: 9352126
[TBL] [Abstract][Full Text] [Related]
44. Type III aminoterminal propeptide of procollagen in some haematological malignancies.
Arrago JP; Poirier O; Chomienne C; D'Agay MF; Najean Y
Scand J Haematol; 1986 Mar; 36(3):288-94. PubMed ID: 3704553
[TBL] [Abstract][Full Text] [Related]
45. Serum concentrations of N-terminal propeptide of type III procollagen and laminin in the outflow of fibrotic livers compared with liver-distal regions.
Gressner AM; Tittor W; Negwer A
Hepatogastroenterology; 1986 Oct; 33(5):191-5. PubMed ID: 3804173
[TBL] [Abstract][Full Text] [Related]
46. Use of various epithelial tumor markers and a stromal marker in the assessment of cervical carcinoma.
Tomás C; Risteli J; Risteli L; Vuori J; Kauppila A
Obstet Gynecol; 1991 Apr; 77(4):566-72. PubMed ID: 2002979
[TBL] [Abstract][Full Text] [Related]
47. The blue glass and the predictive value of serum amino-terminal propeptide of type III procollagen as a marker of liver fibrosis.
Rojkind M
Hepatology; 1984; 4(5):977-8. PubMed ID: 6479861
[No Abstract] [Full Text] [Related]
48. Estimation of the production rates of serum aminoterminal propeptide of type III procollagen and laminin in human fibrotic liver.
Gressner AM; Kropf J; Tittor W
J Clin Chem Clin Biochem; 1987 Sep; 25(9):553-9. PubMed ID: 3681195
[TBL] [Abstract][Full Text] [Related]
49. Procollagen Type I and III Aminoterminal Propeptide Levels and Severity of Interstitial Lung Disease in Mexican Women With Progressive Systemic Sclerosis.
Gonzalez-Lopez L; Rocha-Muñoz AD; Olivas-Flores EM; Garcia-Gonzalez A; Peguero-Gómez AR; Flores-Navarro J; Villa-Manzano AI; Zavaleta-Muñiz SA; Salazar-Paramo M; Mejía M; Juárez-Contreras P; Vazquez-Del Mercado M; Cardona-Muñoz EG; Trujillo-Hernández B; Nava-Zavala AH; Gamez-Nava JI
Arch Bronconeumol; 2015 Sep; 51(9):440-8. PubMed ID: 25301411
[TBL] [Abstract][Full Text] [Related]
50. Macrophage colony-stimulating factor 1, a clinically useful tumor marker in endometrial adenocarcinoma: comparison with CA 125 and the aminoterminal propeptide of type III procollagen.
Hakala A; Kacinski BM; Stanley ER; Kohorn EI; Puistola U; Risteli J; Risteli L; Tomás C; Kauppila A
Am J Obstet Gynecol; 1995 Jul; 173(1):112-9. PubMed ID: 7631667
[TBL] [Abstract][Full Text] [Related]
51. Comparison of serum procollagen III peptide concentrations and PGA index for assessment of hepatic fibrosis.
Teare JP; Sherman D; Greenfield SM; Simpson J; Bray G; Catterall AP; Murray-Lyon IM; Peters TJ; Williams R; Thompson RP
Lancet; 1993 Oct; 342(8876):895-8. PubMed ID: 8105167
[TBL] [Abstract][Full Text] [Related]
52. Heterogeneity of the antigens related to the aminoterminal propeptide of type III procollagen in human serum.
Niemelä O; Risteli L; Sotaniemi EA; Risteli J
Clin Chim Acta; 1982 Sep; 124(1):39-44. PubMed ID: 7127838
[TBL] [Abstract][Full Text] [Related]
53. Risk of liver disease in patients with psoriasis, psoriatic arthritis, and rheumatoid arthritis receiving methotrexate: A population-based study.
Gelfand JM; Wan J; Zhang H; Shin DB; Ogdie A; Syed MN; Egeberg A
J Am Acad Dermatol; 2021 Jun; 84(6):1636-1643. PubMed ID: 33607181
[TBL] [Abstract][Full Text] [Related]
54. Enhanced liver fibrosis test in patients with psoriasis, psoriatic arthritis and rheumatoid arthritis: a cross-sectional comparison with procollagen-3 N-terminal peptide (P3NP).
van der Voort EAM; Wakkee M; Veldt-Kok P; Darwish Murad S; Nijsten T
Br J Dermatol; 2017 Jun; 176(6):1599-1606. PubMed ID: 27925155
[TBL] [Abstract][Full Text] [Related]
55. Aminoterminal propeptide of type-III procollagen in serum--an indicator of clinical behavior of advanced ovarian carcinoma?
Risteli L; Kauppila A; Mäkilä UM; Risteli J
Int J Cancer; 1988 Mar; 41(3):409-14. PubMed ID: 3346105
[TBL] [Abstract][Full Text] [Related]
56. Synovial fluid and serum concentrations of aminoterminal propeptide of type III procollagen in healthy volunteers and patients with joint disease.
Sharif M; George E; Dieppe PA
Ann Rheum Dis; 1996 Jan; 55(1):47-51. PubMed ID: 8572734
[TBL] [Abstract][Full Text] [Related]
57. Procollagen type III aminoterminal peptide in serum in idiopathic myelofibrosis and allied conditions: relation to disease activity and effect of chemotherapy.
Hasselbalch H; Junker P; Hørslev-Petersen K; Lisse I; Bentsen KD
Am J Hematol; 1990 Jan; 33(1):18-26. PubMed ID: 2293759
[TBL] [Abstract][Full Text] [Related]
58. [Serum aminoterminal procollagen type-III peptide in the diagnosis of chronic hepatopathies].
Solís-Herruzo JA; Morillas JD; Vargas J; Colina F; Castellano G; Muñoz Yagüe T; Estenoz J
Med Clin (Barc); 1992 May; 99(1):1-5. PubMed ID: 1602891
[TBL] [Abstract][Full Text] [Related]
59. The aminoterminal-type-III procollagen peptide and proteoglycans in serum and synovial fluid of patients with rheumatoid arthritis or reactive arthritis.
Hørslev-Petersen K; Saxne T; Haar D; Thomsen BS; Bentsen KD; Junker P; Lorenzen I
Rheumatol Int; 1988; 8(1):1-9. PubMed ID: 3259005
[TBL] [Abstract][Full Text] [Related]
60. Autoimmune hepatitis as an adverse effect of long-term methotrexate therapy.
Ksouda K; Affes H; Atheymen R; Ezzeddine M; Zeghal K; Hammami S
Indian J Pharmacol; 2014; 46(6):649-50. PubMed ID: 25538339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
